Epilepsy, Antiepileptic Drugs, and Serious Transport Accidents: A Nationwide Cohort Study

Overview

Journal Neurology

Specialty Neurology

Date 2018 Mar 2

PMID 29490912

Citations 12

Authors

Helene E K Sundelin

Zheng Chang

Henrik Larsson

Paul Lichtenstein

Catarina Almqvist

Torbjorn Tomson

Jonas F Ludvigsson

Affiliations

Soon will be listed here.

Abstract

Objectives: To investigate the association between epilepsy and antiepileptic drugs and serious transport accidents requiring emergency care or resulting in death.

Methods: We identified 29,220 individuals 18 years or older with epilepsy without cerebral palsy or intellectual disability and 267,637 matched controls using Swedish registers. This nationwide cohort was followed from 2006 to 2013 for serious transport accidents. We used Cox regression to analyze the risk of serious transport accidents between individuals with epilepsy and matched controls, and then stratified Cox regression to compare the risk during periods of medication with the risk during nonmedication period within the same individual with epilepsy. We adjusted for civil status, employment, education, living area, psychiatric disorders prior to the start of follow-up, and psychotropic medication.

Results: Compared to matched controls, individuals with epilepsy were at increased risk of serious transport accidents (hazard ratio [HR] 1.37; 95% confidence interval [CI] 1.29-1.46). There were increased risks of pedestrian accidents (HR 2.24, 95% CI 1.69-2.97), bicycle accidents (HR 1.68, 95% CI 1.49-1.89) and car accidents (HR 1.31, 95% CI 1.19-1.44). However, among patients with a diagnosis of epilepsy, use of antiepileptic drugs did not influence the risk of serious transport accidents in population-level comparisons (HR 0.97; 95% CI 0.85-1.11) or within-individual comparisons (HR 0.99; 95% CI 0.69-1.42).

Conclusion: Serious transportation accidents were more common in individuals with epilepsy, but this risk was independent of use of antiepileptic drugs.

Citing Articles

Effects of frequently prescribed antiseizure medications on motor vehicle driving performance: Narrative review based on a tiered approach for the assessment of clinically meaningful driving impairment in the Ministry of Health, Labour, and Welfare....

Iwamoto K, Nakabayashi T, Yamaguchi A, Konishi Y, Saji M, Yoshimura R Neuropsychopharmacol Rep. 2024; 44(4):682-687.

PMID: 39497515 PMC: 11609745. DOI: 10.1002/npr2.12469.

Implications of using administrative healthcare data to identify risk of motor vehicle crash-related injury: the importance of distinguishing crash from crash-related injury.

Joyce N, Lombardi L, Pfeiffer M, Curry A, Margolis S, Ott B Inj Epidemiol. 2024; 11(1):38.

PMID: 39135173 PMC: 11318118. DOI: 10.1186/s40621-024-00523-3.

Driving performance of patients with epilepsy undergoing antiepileptic monotherapy.

Iwamoto K, Saji M, Matsuoka E, Kanemoto K PCN Rep. 2024; 2(1):e83.

PMID: 38868413 PMC: 11114256. DOI: 10.1002/pcn5.83.

Predictive Power of Interictal Epileptiform Discharges in Fitness-to-Drive Evaluation.

Krestel H, Schreier D, Sakiri E, von Allmen A, Abukhadra Y, Nirkko A Neurology. 2023; 101(9):e866-e878.

PMID: 37414567 PMC: 10501101. DOI: 10.1212/WNL.0000000000207531.

Causes of fatalities in motor vehicle occupants: an overview.

ODonovan S, Van Den Heuvel C, Baldock M, Byard R Forensic Sci Med Pathol. 2022; 18(4):511-515.

PMID: 35881221 PMC: 9636288. DOI: 10.1007/s12024-022-00503-3.

References

Ludvigsson J, Almqvist C, Edstedt Bonamy A, Ljung R, Michaelsson K, Neovius M . Registers of the Swedish total population and their use in medical research. Eur J Epidemiol. 2016; 31(2):125-36. DOI: 10.1007/s10654-016-0117-y. View

Chang Z, Lichtenstein P, DOnofrio B, Sjolander A, Larsson H . Serious transport accidents in adults with attention-deficit/hyperactivity disorder and the effect of medication: a population-based study. JAMA Psychiatry. 2014; 71(3):319-25. PMC: 3949159. DOI: 10.1001/jamapsychiatry.2013.4174. View

Aschkenasy M, Drescher M, Ratzan R . Physician reporting of medically impaired drivers. J Emerg Med. 2006; 30(1):29-39. DOI: 10.1016/j.jemermed.2005.04.015. View

Ludvigsson J, Andersson E, Ekbom A, Feychting M, Kim J, Reuterwall C . External review and validation of the Swedish national inpatient register. BMC Public Health. 2011; 11:450. PMC: 3142234. DOI: 10.1186/1471-2458-11-450. View

Gopinath B, Jagnoor J, Craig A, Kifley A, Dinh M, Ivers R . Describing and comparing the characteristics of injured bicyclists and other injured road users: a prospective cohort study. BMC Public Health. 2016; 16:324. PMC: 4831149. DOI: 10.1186/s12889-016-2988-y. View

Donnelly-Swift E, Kelly A . Factors associated with single-vehicle and multi-vehicle road traffic collision injuries in Ireland. Int J Inj Contr Saf Promot. 2015; 23(4):351-361. DOI: 10.1080/17457300.2015.1047861. View

Rai D, Kerr M, McManus S, Jordanova V, Lewis G, Brugha T . Epilepsy and psychiatric comorbidity: a nationally representative population-based study. Epilepsia. 2012; 53(6):1095-103. DOI: 10.1111/j.1528-1167.2012.03500.x. View

Nilsson L, Tomson T, Farahmand B, Diwan V, Persson P . Cause-specific mortality in epilepsy: a cohort study of more than 9,000 patients once hospitalized for epilepsy. Epilepsia. 1998; 38(10):1062-8. DOI: 10.1111/j.1528-1157.1997.tb01194.x. View

Berg A, Engel Jr J . Restricted driving for people with epilepsy. Neurology. 1999; 52(7):1306-7. DOI: 10.1212/wnl.52.7.1306. View

10.

Naik P, Fleming M, Bhatia P, Harden C . Do drivers with epilepsy have higher rates of motor vehicle accidents than those without epilepsy?. Epilepsy Behav. 2015; 47:111-4. DOI: 10.1016/j.yebeh.2015.04.016. View

11.

Drazkowski J, Fisher R, Sirven J, Demaerschalk B, Uber-Zak L, Hentz J . Seizure-related motor vehicle crashes in Arizona before and after reducing the driving restriction from 12 to 3 months. Mayo Clin Proc. 2003; 78(7):819-25. DOI: 10.4065/78.7.819. View

12.

Orriols L, Avalos-Fernandez M, Moore N, Philip P, Delorme B, Laumon B . Long-term chronic diseases and crash responsibility: a record linkage study. Accid Anal Prev. 2014; 71:137-43. DOI: 10.1016/j.aap.2014.05.001. View

13.

Brodie M . Outcomes in newly diagnosed epilepsy in adolescents and adults: Insights across a generation in Scotland. Seizure. 2016; 44:206-210. DOI: 10.1016/j.seizure.2016.08.010. View

14.

Lings S . Increased driving accident frequency in Danish patients with epilepsy. Neurology. 2001; 57(3):435-9. DOI: 10.1212/wnl.57.3.435. View

15.

Classen S, Crizzle A, Winter S, Silver W, Eisenschenk S . Evidence-based review on epilepsy and driving. Epilepsy Behav. 2012; 23(2):103-12. DOI: 10.1016/j.yebeh.2011.11.015. View

16.

Ludvigsson J, Haberg S, Knudsen G, Lafolie P, Zoega H, Sarkkola C . Ethical aspects of registry-based research in the Nordic countries. Clin Epidemiol. 2015; 7:491-508. PMC: 4664438. DOI: 10.2147/CLEP.S90589. View

17.

Brunbech L, Sabers A . Effect of antiepileptic drugs on cognitive function in individuals with epilepsy: a comparative review of newer versus older agents. Drugs. 2002; 62(4):593-604. DOI: 10.2165/00003495-200262040-00004. View

18.

Wettermark B, Hammar N, Fored C, MichaelFored C, Leimanis A, Olausson P . The new Swedish Prescribed Drug Register--opportunities for pharmacoepidemiological research and experience from the first six months. Pharmacoepidemiol Drug Saf. 2006; 16(7):726-35. DOI: 10.1002/pds.1294. View

19.

Kwan P, Brodie M . Early identification of refractory epilepsy. N Engl J Med. 2000; 342(5):314-9. DOI: 10.1056/NEJM200002033420503. View

20.

Winston G, Jaiser S . Western driving regulations for unprovoked first seizures and epilepsy. Seizure. 2012; 21(5):371-6. DOI: 10.1016/j.seizure.2012.03.008. View